Skip to main content
. Author manuscript; available in PMC: 2017 Apr 19.
Published in final edited form as: Vaccine. 2016 Mar 12;34(18):2096–2105. doi: 10.1016/j.vaccine.2016.03.006

Figure 1.

Figure 1

Subject Disposition Through Day 84.

F/U=follow up; ITT=intent to treat; OOO=out of window; Plc=placebo; TNA=toxin neutralizing antibody. Subjects were randomized to 1 of 5 study groups at a 4:3:2:4:2 ratio. One-hundred sixty-eight subjects were randomized and received at least one vaccination; 158 subjects completed the in-clinic visits through Day 84; and 147 subjects completed the in-clinic visits through Day 84 and received all 3 vaccinations.